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Graphical Abstract 
 
By assessing multiple positive and negative markers of forebrain progenitors and 
neurons, the authors show that now-standard, partially directed neocortical 
differentiation of mouse embryonic stem cells generates neurons that most closely 
resemble neocortical projection neurons during mid-corticogenesis. These neurons are 
“stalled” in subtype-specific molecular refinements, as compared to primary, dissociated 
E15.5 neocortical neurons cultured under the same in vitro conditions. 
 (58 words; 50 max; Graphical Abstract Text filetype in ScholarOne Manuscripts)   
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Abstract 
 Two existing and widely applied protocols of embryonic stem (ES) cell 
differentiation have been developed to enable in vitro generation of neurons resembling 
neocortical projection neurons in monolayer culture (Gaspard et al., 2008; Espuny-
Camacho et al. 2013) and from embryoid bodies (Eiraku et al., 2008; Nasu et al., 2012). 
The monolayer approach offers advantages for detailed in vitro characterizations and 
potential mechanistic and therapeutic screening. 
 We investigated whether mouse ES cells undergoing largely undirected 
neocortical differentiation in monolayer culture recapitulate progressive developmental 
programs of in vivo progenitor and post-mitotic differentiation, and whether they develop 
into specific neocortical subtypes. We find that ES-derived mitotic cells that have been 
dorsalized by the sonic hedgehog antagonist cyclopamine, and that express, as a total 
population, cardinal markers of telencephalic progenitors, are, in fact, molecularly 
heterogeneous. We next show that these progenitors subsequently generate small 
numbers of heterogeneous neocortical-like neurons that are “stalled” at an immature 
stage of differentiation, based on multiple developmental criteria.  
 While some aspects of neocortical development are recapitulated by existing 
protocols of ES cell differentiation, these data indicate that mouse ES-derived 
neocortical progenitors are both more heterogeneous than their in vivo counterparts, 
and seemingly include many incorrectly specified progenitors. Further, these ES-derived 
progenitors spontaneously differentiate into sparse, incompletely and largely imprecisely 
differentiated, neocortical-like neurons that fail to adopt specific neuronal identities in 
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vitro. These results provide both foundation and motivation for refining and enhancing 
directed differentiation of clinically important neocortical projection neuron subtypes. 
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Introduction 
 Neocortical projection neurons undergo distinct molecular refinements at 
progenitor (Molyneaux et al., 2005; Chen et al., 2005; Chen et al., 2008; Azim et al., 
2009) and post-mitotic (Weimann et al., 1999; Arlotta et al., 2005; Alcamo et al., 2008; 
Britanova et al., 2008; Lai et al., 2008; Joshi et al., 2008; Azim et al., 2009; Tomassy et 
al., 2010; Cederquist et al., 2013) stages of development. These molecular refinements 
individually represent distinct developmental programs that, in sequential combinations, 
control neocortical development. In the absence of these critical transcriptional 
regulators that control any of these stages, the precise molecular identity, laminar/area 
positioning, and/or projection patterns of neocortical projection neuron subtypes are 
disrupted in vivo. These transcriptional controls, therefore, are good candidates for 
rigorous characterization of in vitro neocortical-like neurons derived from embryonic 
stem (ES) cells. 
 Recent advances in mouse ES cell directed neocortical differentiation 
recapitulate some, but not all, aspects of corticogenesis (Gaspard et al., 2008; Eiraku et 
al., 2008; Nasu et al., 2012; Hansen et al., 2011). Importantly, populations of ES-
derived neocortical-like neurons sequentially express single genes characteristic of 
neocortical neurons in vivo. However, many of these genes (e.g., Pax6, Ctip2, Satb2) 
are not specific only to the neocortex, but are expressed in other regions of the 
developing neural tube. For example, Pax6 is differentially expressed throughout the 
rostro-caudal extent of the neural tube ventricular zone (Ericson et al., 1997; Osumi et 
al., 1997; Briscoe et al., 2000; Alaynick et al., 2011), and Ctip2 is also expressed in 
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striatum, olfactory bulb, and hippocampus (Leid et al., 2004; Arlotta et al., 2005; Arlotta 
et al., 2008).  
 With deeper analysis, using multiple markers, it is increasingly apparent that ES-
derived neocortical-like neurons are incompletely specified in vitro. First, a substantial 
fraction of these neurons express combinations of molecular markers that are not 
described in the neocortex in vivo (e.g., Reelin/Ctip2; Gaspard et al., 2008). Second, 
ES-derived neocortical neurons often display mixed subtype-specific molecular 
characteristics, such as co-expression of deep- and superficial-layer markers in 
individual hES-derived neurons (Mariani et al., 2012; Shi et al., 2012). Finally, these 
neurons display skewed areal specification and projection patterns to visual and limbic 
targets (Gaspard et al., 2008; Espuny-Camacho et al., 2013). These subtle but distinct 
deficiencies in the differentiation of ES-derived neocortical neurons suggest incomplete 
differentiation, which might hinder neocortical subtype acquisition, and limit the 
interpretability of these in vitro models of corticogenesis. 
 More refined characterizations of in vitro neocortical differentiation are now 
possible, given recent advances in the study of neocortical development (Molyneaux et 
al., 2007; Woodworth et al., 2012; Custo Greig et al., 2013). Pax6, often used to 
exclusively mark the pallium, is not a specific marker of the pallial tissue, given its 
expression throughout the neural tube (Alaynick et al., 2011). In the absence of 
positional information in vitro, characterization of Pax6-expressing “pallial” progenitors is 
incomplete without the presence of additional markers of pallial progenitors (e.g., Sox6; 
Azim et al., 2009; Otx2, Acampora et al., 1999), or the absence of other markers co-
expressed with Pax6 outside of the pallium.  
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 Sox6 is a transcription factor that controls the development of pallial progenitors 
independently from Pax6; its absence results in misspecification of pallial progenitors, 
by ectopic expression of subpallial genes (Azim et al., 2009). Like Pax6, Sox6 is not 
specific to the pallium, as it is also expressed by post-mitotic, subpallium-derived 
interneurons. However, when Sox6 is assessed in combination with Pax6, the presence 
of both markers greatly increases the specificity for pallial progenitors. To date, this 
combination has not been used for the identification of pallial progenitors in vitro.  
 Post-mitotic neocortical neurons in vivo undergo a prolonged maturation process, 
during which gene expression becomes progressively restricted to particular subtypes 
(Lai et al., 2008; Britanova et al., 2008; Alcamo et al., 2008; Chen et al., 2008; Azim et 
al., 2009; Joshi et al., 2008; Woodworth et al., 2012; Cederquist et al., 2013; Custo 
Greig et al., 2013). These neurons initially co-express transcriptional controls 
characteristic of multiple neocortical projection subtypes (e.g., Tbr1, Ctip2, Satb2, 
Clim1, Lmo4) and multiple neocortical area identities (e.g., CoupTF1, Bhlhb5, Lmo4) 
before distinct subtype identities emerge. Together, this process of molecular 
refinement involves, at minimum, coordinated neuronal maturation, neocortical 
projection neuron class distinction, and neocortical area subtype distinction. These 
three stage-specific features of neocortical identity refinement form the basis for our 
approach to characterizing neocortical identity in vitro, presented here. 
 We assessed mouse ES cell-derived neocortical-like neurons at progenitor and 
post-mitotic stages, and identified multiple characteristics consistent with stalled 
maturation. First, ES-derived neocortical-like progenitors are more heterogeneous than 
has been previously reported using single-marker analyses. Second, neocortical-like 
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neurons are stalled at a maturation stage resembling mid-corticogenesis, as indicated 
by overlapping expression of multiple subtype-specific markers that do not resolve with 
time. Additionally, area-specific differentiation is abnormal, as ES-derived neocortical 
neurons are deficient in the sensori-motor cortex regulator of neocortical development, 
Bhlhb5. Overall, this approach rigorously investigates the refinement of ES-derived 
neocortical differentiation, and indicates directions for refining directed differentiation of 
clinically important neocortical projection neurons. 
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Materials and Methods 
 
Cell culture and differentiation 
 Murine embryonic stem cells: Nagy ES cell line G4 (MMRRC stock# 011987-MU) 
or feeder-free E14Tg2a (Baygenomics) mouse embryonic stem cells were propagated 
using standard procedures (Ying et al., 2003) on gelatin-coated (0.1% gelatin, StemCell 
Technologies) cell culture treated plastic dishes. Nagy ES cells were cultured on mouse 
embryonic fibroblast feeder cells (Millipore EmbryoMax PMEF-N). Mouse embryonic 
stem cell media is GMEM (Invitrogen) supplemented with 10% ESC-certified fetal 
bovine serum (vol/vol, Invitrogen), 0.1 mM nonessential amino acids (Invitrogen), 1mM 
sodium pyruvate (Invitrogen), 0.1mM β-mercaptoethanol (Sigma), 50 U/mL 
penicillin/streptomycin and 1000 U/mL leukemia inhibitor factor (ESGRO).  
 For differentiation, Nagy G4 and E14Tg2a ES cells were plated at low density 
(5,000 cells/cm2) on gelatin-coated plastic dishes in ES cell medium, and cultured as 
described (Gaspard et al., 2009). Briefly, ESCs were trypsinized, dissociated, and 
plated on gelatin-coated cell culture plates. Medium was changed to DDM after one 
day. DDM consists of DMEM/F12 (Invitrogen-Gibco) supplemented with N2 supplement 
(N2 supplement consists of 8.61uM insulin, 1mM transferrin, 2uM progesterone, 10mM 
putrescine and 3uM selenite; Invitrogen-Gibco), 2mM glutamine, 0.1 mM nonessential 
amino acids, 1mM sodium pyruvate, 0.5 mg/ml bovine serum albumin fraction V (all 
from Invitrogen-Gibco), and 0.1mM β-mercaptoethanol (Sigma).  
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 Cyclopamine (Calbiochem) or Ag1.3 (gift from Lee Rubin, Harvard University) 
was added from day 2 to day 10 in the differentiation medium at a final concentration of 
1uM. After 10 to 14 days of differentiation, cells were trypsinized, dissociated and plated 
on poly-lysine/laminin (Becton-Dickinson) coated glass coverslips, and allowed to grow 
for 4–14 days in N2B27 medium. N2B27 medium consists of a 1:1 mixture of DDM and 
Neurobasal that is supplemented with B27 (without vitamin A; Invitrogen-Gibco) and 2 
mM glutamine. 
Immunocytochemistry 
 Cells were fixed in 4% paraformaldehyde (wt/vol) for 30 min, and washed three 
times in phosphate-buffered saline (PBS). Wide-field image acquisition was performed 
using a Nikon 90i epifluorescence microscope with a Clara DR-328G cooled CCD digital 
camera (Andor Technology, Belfast, Northern Ireland). Confocal imaging was performed 
with a BioRad Radiance 2100 Rainbow laser-scanning confocal microscope based on a 
Nikon E800 microscope. Images were assembled in Adobe Photoshop and Illustrator 
(CS3, CS5), with adjustments for contrast, brightness, and color balance to obtain 
optimal visual reproduction of data. 
Table of Primary Antibodies used 
Antigen Immunogen 
Manufacturer, species, 
mono- vs. polyclonal, 
catalog number 
Dilution 
used 
Pax6 
QVPGSEPDMSQYWPRLQ 
derived from the C-terminus of 
mouse Pax-6 protein 
Covance, rabbit polyclonal, 
#PRB-278P 1:300 
Sox6 
synthetic peptide derived from 
<800 residues to the C-terminus 
of mouse SOX, conjugated to 
KLH 
Abcam, rabbit polyclonal, 
#AB30455 1:200 
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Mash1 full length recombinant rat Mash1 protein 
BD, mouse monoclonal,  
#556604 1:500 
Gsh2 
synthetic peptide derived from a 
region between amino acids 1-46 
of human GSH2 
Abcam, rabbit polyclonal, 
#26255 1:500 
Nkx2.1/TTF1 
synthetic peptide containing 
residues 110-122 at the N-
terminus of rat Nkx2.1 
BioPat, mouse monoclonal, 
#PA0100 1:5,000 
Tbr1 
synthetic peptide derived from 
within residues 50-150 of mouse 
TBR1, conjugated to KLH 
Abcam, rabbit polyclonal, 
#31940-100 1:500 
Ctip2 
synthetic protein derived from 
within residues 1-150 of human 
CTIP2 
Abcam, rat monoclonal 
[25B6], #18465-100 1:500 
Satb2 
recombinant human Satb2 
protein containing a fragment of 
the C-terminal 
Abcam, mouse monoclonal 
[SATBA4B10], #51502 1:200 
Er81 
synthetic mouse Er81 C-terminal 
peptide sequence, 
CNPHPYNEGYVY, conjugatd to 
KLH 
Abcam, rabbit polyclonal, 
#AB36788 1:100 
GAD67 recombinant GAD67 protein 
Millipore, mouse 
monoclonal [clone 1G10.2], 
#MAB5406 
1:1000 
TuJ1/β-tubulin III 
synthetic peptide containing 
residues 441-450 of human β-
tubulin III (Ala446 to Ser446 
substitution) with N-terminal 
added cysteine, conjugated to 
KLH 
Sigma, rabbit polyclonal, 
#T2200-200uL 1:1000 
TuJ1/β-tubulin III microtubules derived from rat brain 
Covance, mouse 
monoclonal, #MMS-435P 1:1000 
Map2 full length recombinant bovine Map2 
Sigma, mouse monoclonal, 
#M1406 1:500 
NeuN/Fox-3 
purified cell nuclei from mouse 
brain; recognizes residues 1-106 
of Fox-3 
Millipore, mouse 
monoclonal [A60], 
#MAB377 
1:250 
Bhlhb5 synthetic protein containing the N-terminus of hamster Bhlhb5 
Santa Cruz, goat polyclonal, 
#6045 1:300 
CoupTF1 
synthetic protein containing the 
first 203 residues of mouse 
COUP-TFI 
rabbit polyclonal, gift of the 
Michele Studer lab, Institute 
of Biology Valrose in Nice, 
France 
1:500 
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Antibody Characterization  
Please see Table 1 for a list of all antibodies used.   
The Pax6 antiserum has been widely characterized and used in the field, and 
does not label Pax6 null cells. It is confirmed to be specific to the 
developmental pallial domain by immunocytochemistry. 
The Sox6 antiserum does not stain samples of post-natal brain from a Sox6 
knockout mouse (manufacturer’s data sheet). Identical results in embryonic 
brain tissue were obtained from the Macklis laboratory (Azim et al., Nat. 
Neurosci., 2009). 
The Mash1 antiserum recognizes a single band of 34 kDa molecular weight by 
SDS-PAGE (per manufacturer), with specific staining of the mouse 
subpallium (Yun, Fischman, et al., Development 2002). 
The Gsh2 antiserum recognizes a single band of 35 kDa molecular weight by 
SDS-PAGE (per manufacturer) and is confirmed to be specific to the 
developmental subpallial domain by immunocytochemistry. 
The Nkx2.1/TTF1 antiserum staining is abolished when the diluted primary 
antibody is pre-incubated with 0.1uM of the immunizing peptide (Moreno 
and Gonzalez, 2007) and is confirmed to be specific to the developmental 
subpallial domain by immunocytochemistry. 
The Tbr1 antiserum recognizes a single band of 74 kDa molecular weight by 
SDS-PAGE and stained a pattern of cellular morphology and distribution in 
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the mouse brain that is identical with previous reports (Hevner et al., 
Neuron, 2001) 
The Ctip2 antiserum detects two bands representing Ctip2 at about 120kD by 
SDS-PAGE. No staining is seen on tissue from a Ctip2 knockout mouse 
(Arlotta et al., Neuron, 2005; Arlotta et al., J. Neurosci. 2008). 
The Satb2 antiserum detects one 81kDa band representing Satb2 by SDS-
PAGE. No staining is seen on tissue from a Satb2 knockout mouse 
(Britanova et al., Neuron 2008). 
The Er81 antiserum produced a pattern of immunoreactivity that was identical 
with previous descriptions of E16.5 mouse brain sections (Stenman et al., 
2003; Yoneshima et al., 2006). 
The GAD67 antiserum had no detectable cross reactivity with GAD65 by 
Western blot on rat brain lysate (manufacturer's data sheet). 
The TuJ1/ β-tubulin III antisera is well characterized and highly reactive to neuron 
specific class III β-tubulin (βIII). TuJ1 does not identify β-tubulin found in 
glial cells.  
The MAP2 antiserum localizes the high molecular weight forms of MAP2 (MAP2a 
and MAP2b) but shows no reactivity with MAP2c (manufacturer's data 
sheet). No cross-reactivity is observed with MAP1, MAP5, tubulin, or tau. 
The NeuN (Neuronal Nuclei) antiserum recognizes two major bands of 40 and 50 
kDa by SDS-PAGE. The antiserum recognizes residues 1-106 at the N-
terminal of Fox-3. It is specific to two Fox-3 isoforms, based on absent 
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NeuN staining in Fox-3 null SK-N-SH cells and identical co-localization of 
Fox-3 and NeuN antisera (Kim, Adelstein, and Kawamoto, JBC 2009). 
The Bhlhb5 antiserum does not stain tissue from a Bhlhb5 knockout mouse (data 
not shown, Joshi et al., Neuron 2008). 
The CoupTF1 antiserum did not stain tissue from a CoupTF1 knockout mouse 
(Tripodi et al., Development 2004; Srubek Tomassy et al., PNAS 2010). 
Secondary antibodies were from the Invitrogen Molecular Probes Alexa series. 
Specificity was tested with omission of primary antibodies (data not 
shown). 
Nuclei were stained with Hoechst #33342 (1:3,000, Sigma). 
Mice 
 All mouse studies were approved by the Harvard University and/or 
Massachusetts General Hospital IACUCs, and were performed in accordance with 
institutional and federal guidelines. The date of vaginal plug detection was designated 
E0.5, and the day of birth as P0. Wild-type CD1 mice were used in all experiments 
(Charles River Laboratories). 
 Brains were fixed using standard methods (Fricker-Gates et al., 2002; Arlotta et 
al., 2005). Briefly, brains were fixed by trans-cardial perfusion with PBS–heparin (10 
U/ml), followed by 4% paraformaldehyde, and post-fixed overnight at 4°C in 4% 
paraformaldehyde. Brains were sectioned coronally at 50 um on a vibrating microtome 
(Leica). Coverslips or floating sections were blocked in 1% BSA (Sigma) and 0.1% 
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Triton X-100 (Sigma) for 20min at room temperature, before incubation in primary 
antibody. 
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Results 
 To begin characterizing ES-derived neocortical-like cells, we cultured mouse ES 
cells, and directed their differentiation to neocortical fates using an established 
monolayer cell culture protocol (Gaspard et al., 2008; Gaspard et al., 2009). This 
protocol enables rostral and dorsal differentiation by plating ES cells at low-density, 
removing serum and retinoids, and antagonizing residual Shh morphogen signaling with 
cyclopamine. We replicated this protocol, and generated sequential waves of broad 
neural populations (neural progenitors, immature neurons, and astroglia) from E14Tg2a 
mouse ES cells over the course of 28 days (Figure 1), closely replicating the originally 
published results (Gaspard et al., 2008). After two weeks in culture, 55 +/- 6.8% (mean 
+/- s.e.m.) of ES-derived cells express Nestin, an intermediate filament protein, broadly 
marking neural progenitors. Similar results were obtained using Nagy G4 mouse ES 
cells (data not shown). These results show that both the timing of neural induction, and 
sequential generation of neural progenitors, neurons, and astroglia, are nearly identical 
to previously published results (Gaspard et al., 2008). 
 
Distinct subsets of pallial progenitors are generated from ES cells 
 We first assessed the proportion of rostral, dorsal, pallial-like differentiation by 
ES-derived Nestin-expressing neural progenitors at in vitro day 14. Approximately half 
of Nestin-expressing progenitors are pallial-like, based on co-expression of Pax6 
(Figure 2A). All Pax6-expressing cells co-express Nestin, and Pax6 is not expressed by 
any TuJ1 (beta tubulin III)-expressing immature neurons (data not shown). Together, 
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these data suggest that Pax6 expression is restricted to about half of ES-derived neural 
progenitors. 
 We next asked whether these Pax6-expressing neural progenitors at in vitro day 
14 display other characteristics of pallial progenitors. We hypothesized that correctly-
specified pallial progenitors will co-express Sox6 (Azim et al., 2009). Similar to the 
proportion of Pax6-expressing progenitors, we find that approximately half of Nestin-
expressing progenitors also express Sox6 (Figure 2B). However, Pax6 and Sox6 are 
co-expressed by only approximately 20% of progenitors (Figure 2C), which is strikingly 
dissimilar to their highly overlapping expression in vivo (Azim et al., 2009). Overall, the 
combined distribution of Pax6 and Sox6 expression accounts for the majority of Nestin-
expressing progenitors at day 14, but these pallial transcription factor controls are 
largely not expressed by the same cells. 
 Since most Pax6-expressing cells do not co-express Sox6, we hypothesized that 
some Pax6-expressing cells might possess identities characteristic of a position in the 
neural tube caudal to the telencephalon. Otx2, expressed throughout the ventricular 
zone of the neural tube rostral to the hindbrain, demarcates the midbrain-hindbrain 
boundary, and is required for early specification of forebrain and midbrain (Acampora et 
al., 1999). We find that the majority of Pax6-expressing pallial-like progenitors co-
express Otx2, consistent with a forebrain progenitor identity (Figure 2D). Otx2 is also 
co-expressed by most Sox6-expressing progenitors (Figure 2E). While these data 
suggest that many Pax6- and Sox6-expressing progenitors resemble forebrain pallial 
progenitors, the absence of Otx2 co-expression in many progenitors indicates further 
heterogeneity not observed in vivo. 
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 To assess whether downstream pallial molecular programs are intact in cells 
differentiating under these conditions, we assessed expression of Ngn2 in these ES-
derived pallial-like progenitors. In the developing pallium, Pax6 and Sox6 are both 
upstream of Ngn2, a pro-neurogenic transcription factor that has cell cycle dependent 
expression in progenitors undergoing neurogenesis (Azim et al., 2009; Kageyama et al., 
2008; Ma et al., 2008; Schuurmans et al., 2004). We find that Ngn2 is highly expressed 
by cells with low Pax6 expression, suggesting that ES-derived pallial-like progenitors 
are undergoing neurogenesis with dynamic regulation of Pax6 and Ngn2 (Figure 2F). 
 To investigate whether pallial-like progenitors appropriately exclude markers of 
subpallial identity, we tested for molecular markers of these populations at in vitro day 
14. Mash1, also called Ascl1, is a transcription factor expressed in the subpallium (both 
lateral and medial ganglionic eminences) and at the adjacent pallial-subpallial boundary; 
in concert with Dlx1/2, it is essential for the proper specification of subpallium-derived 
neurons (Long et al., 2009). We find that Mash1 is co-expressed by approximately 10% 
of Nestin-expressing ES-derived progenitors (Figure 2G).  
 To investigate whether Mash1-expressing progenitors display other 
characteristics of subpallial progenitors, we assessed their co-expression with Gsh2 
and/or Nkx2.1. Gsh2 is a transcription factor expressed by early progenitors of the 
lateral ganglionic eminence, and, to a lesser extent, the medial ganglionic eminence; 
Gsh2 functions upstream of Mash1 activation, and represses Pax6 transcription (Corbin 
et al., 2003; Wang et al., 2009; Pei et al., 2011; Azim et al., 2009; Batista-Brito et al., 
2009). Nkx2.1 is another subpallial control, expressed in the medial ganglionic 
eminence (Butt et al., 2008). Gsh2 and Nkx2.1 are individually co-expressed with 
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Mash1 in the subpallium, in distinct compartments; we hypothesized that some Mash1-
expressing progenitors might co-express one or both these subpallial transcription 
factors. However, we find that Gsh2 and Nkx2.1 expression is absent in ES-derived 
progenitors (data not shown). 
 To determine whether this protocol is competent to generate cells with 
appropriate subpallial characteristics, we directed the ventralization of ES-derived 
neural progenitors with Shh agonism. In the presence of the Shh agonist Ag1.3, Pax6 
expression is appropriately lost (Figure 2H), while expression of Nkx2.1 and Gsh2, 
individually, is increased (Figure 2I,J). Mash1 expression was not affected (data not 
shown). These data provide a positive control for the absence of Gsh2 and Nkx2.1 
expression with cyclopamine-mediated dorsal differentiation, confirming that subpallial 
gene expression by ES-derived progenitors is Shh-dependent, as expected in vivo. In 
contrast, Mash1 expression by a subpopulation of these cells appears to be 
independent of subpallial specification. 
 We next asked whether Mash1-expressing progenitors are instead pallial-like, 
given previous reports of cells with Mash1 expression in the dorsal pallium and at the 
pallial-subpallial boundary in vivo (Britz et al., 2006; Ge et al., 2006). While pallial 
progenitors expressing Pax6 (Figure 2K) or Sox6 (Figure 2L) are mostly distinct from 
Mash1-expressing progenitors, we find that approximately 15% of Pax6-expressing 
progenitors co-express Mash1 (Figure 2K). These findings suggest that many Mash1-
expressing ES-derived progenitors are potentially pallial. This interpretation is 
consistent with the broad dorsalization induced by cyclopamine in ES cell differentiation, 
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but again highlights a high degree of heterogeneity within ES-derived pallial-like 
progenitors by day 14. 
 
A small subset of ES-derived neurons is neocortical, based on multiple markers  
 At 21 days of differentiation, 31 +/- 3.3% (mean +/- s.e.m.) of cells express TuJ1, 
and can be considered immature neurons, although this proportion is highly variable 
(Figure 1G and 3A,B). Previous reports using this protocol have indicated that a higher 
proportion of ES-derived neurons are generated (Gaspard et al., 2008; Gaspard et al., 
2009), which raises specific methodological points that might explain the quantitative 
differences we observe. First, the ES-derived cells produced by this monolayer protocol 
do not remain a monolayer after greater than seven days of differentiation; at later 
times, we observe cell overgrowth and “clumping” of cells with heterogeneous 
morphologies. We use confocal imaging to more precisely localize TuJ1 staining near 
areas of dense cell over-growth at day 21. Counting total nuclei within aggregates of 
cells has not proved reliable, and we therefore excluded neurons found within these 
dense aggregates. Second, we maintained strict criteria for counting TuJ1-expressing 
neurons: TuJ1 staining must minimally encompass a hemi-circle around the nucleus, 
and display a polarized, neuron-like morphology. Third, because TuJ1 expression is not 
entirely specific to neurons (e.g., TuJ1 is expressed by fibroblasts; Vierbuchen et al., 
2010), we excluded non-neuronal TuJ1-expressing cells based on multiple exclusion 
criteria: comparatively lower intensity of TuJ1 expression, fibroblast-like morphology, or 
any nuclei surrounded by an exceedingly high density of neurites from adjacent 
neurons, which can sometimes incorrectly resemble distinct neurons. Finally, TuJ1 
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expression is not distributed uniformly in vitro across a coverslip, and all 
characterizations were performed on selected imaging fields containing substantial 
numbers of neurons. 
 To investigate the potentially neocortical identity of these ES-derived neurons at 
day 21, we performed immunostaining for multiple neuronal markers. We first assessed 
the expression of Tbr1, which is expressed briefly by all post-mitotic pyramidal neurons 
generated in the developing pallium, before its expression becomes restricted to 
corticothalamic projection neurons (CThPN) and callosal projection neurons (CPN) in 
layer VI (Englund et al., 2005; Hevner et al., 2001). Tbr1 is expressed in few brain areas 
other than neocortex, and Tbr1-expressing neurons are glutamatergic (Hevner et al., 
2001; Bedogni et al., 2010; McKenna et al., 2011). Approximately 10-20% of TuJ1-
expressing neurons in vitro also express Tbr1 (Figure 3A). Given the low percentage of 
ES-derived neurons expressing Tbr1, we imaged selected fields containing relatively 
high concentrations of Tbr1-expressing neurons for further subtype characterization.  
To identify cells with properties of early neocortical neurons, and potentially of 
specific deep-layer subtypes, we focused on expression of Ctip2. Like Tbr1, Ctip2 is a 
critical transcription factor expressed at distinct levels (off, low, high) by multiple newly 
post-mitotic neocortical subtypes; later in development, Ctip2 controls corticofugal 
projection neuron (CFuPN) axon outgrowth and fasciculation, with refined laminar 
expression specific to deep layers – low level by CThPN in layer VI, and high level by 
SCPN in layer V (Arlotta et al., 2005). Expression of Ctip2 by immature CPN, and 
therefore co-expression with CPN marker Satb2, is lost by late embryogenesis (Alcamo 
et al., 2008; Britanova et al., 2008; Chen et al., 2008). Importantly, Ctip2 is highly 
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expressed in brain regions other than the neocortex, most highly by medium-sized spiny 
neurons in the striatum (Leid et al., 2004; Arlotta et al., 2005; Arlotta et al., 2008). 
We find that Ctip2, similarly to Tbr1, is expressed by a modest fraction of TuJ1-
expressing neurons (approximately 10-20% of neurons in selected fields containing 
positive Ctip2 staining) (Figure 3B). If these Ctip2-expressing neurons are neocortical-
like, we hypothesized that most should also express Tbr1. Consistent with this 
prediction, Ctip2 and Tbr1 display nearly complete co-expression after 21 days in 
culture (Figure 3C). These data suggest that this sparse population of ES-derived 
Ctip2-expressing neurons is glutamatergic, and most closely resembles immature deep-
layer projection neurons. 
 To rigorously investigate whether these Ctip2 and Tbr1 co-expressing neurons 
represent non-neocortical neurons, we performed co-expression analysis of Ctip2 with 
Er81 and GAD67. Er81 is expressed in neocortical deep layers, olfactory bulb 
(interneurons), amygdala, thalamus, but not in striatum (Stenman et al., 2003; 
Yoneshima et al., 2006); the intersection of Er81 and Ctip2 expression is fairly exclusive 
to neocortex. We find that Ctip2-expressing neurons co-express Er81 in the cytoplasm 
(Figure 3D), which indicates that they are not striatal. Many important striatal genes, 
such as Darpp32, Foxp1, and Foxp2, are expressed both in cortex and in striatum, and 
we therefore examined expression of GAD67, which is expressed only by GABAergic 
inhibitory populations, such as medium-sized spiny neurons and subpallium-derived 
cortical interneurons (reviewed in Gord and Bernardo, 2011). We find that the ES-
derived neurons expressing Ctip2 do not co-express GAD67, and, therefore, are not 
GABAergic (Figure 3D). Together, the co-expression of Ctip2, Er81, and Tbr1, and the 
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absence of GAD67, strongly support the interpretation that a small proportion of ES-
derived neurons under these relatively undirected conditions adopt properties of 
immature neocortical neurons in vitro. 
 
Neocortical neurons are relatively immature  
 To investigate whether neocortical-like Ctip2-expressing neurons display 
appropriate features of stage-specific differentiation, we first assessed basic markers of 
neuronal maturation. Nearly all CNS neurons activate common programs of neuronal 
maturation, as marked by TuJ1, Map2, and NeuN/Fox-3 (Kim et al., 2009). Very few 
mature neurons in the CNS lack NeuN expression, most notably Purkinje neurons and 
gamma spinal motor neurons (Friese et al., 2009). 
 We find that these ES-derived neurons are relatively immature, based on the low 
abundance of NeuN expression after 21 or 28 days (approximately 5-10% of TuJ1-
positive neurons co-express NeuN, assessed in selected fields in vitro). Given the 
importance of neuronal maturation for the timing of post-mitotic neocortical subtype 
refinement, we asked whether the small population of neocortical-like neurons that co-
express Ctip2, Tbr1, and Er81 is mature or immature. We find that all Ctip2-expressing 
neurons co-express TuJ1 (Figure 3B). Approximately one third of these neurons 
express both Map2 and NeuN (Figure 4A). These neurons are not uniformly or 
completely mature, but some display crucial hallmarks of at least early maturation. 
 We next investigated whether the extent of NeuN expression might indicate an 
equivalent stage in development. In vivo at E16.5-E18.5, NeuN is expressed by 
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approximately one-third of of Ctip2-expressing neocortical neurons (Figure 4B,C). 
Later, at P6, all Ctip2-expressing neocortical neurons also express NeuN (Figure 4D). 
Between E16.5 and P6, Ctip2-expressing cortical neurons in vivo extend axons to their 
targets in the midbrain, brainstem, and spinal cord, and begin the process of pruning 
collateral connections (Arlotta et al., 2005; Stanfield, 1992). In contrast, ES-derived 
neocortical neurons in culture develop to a relatively immature state most highly 
resembling mid-corticogenesis. 
 
Impaired subtype distinction of immature ES-derived CFuPN 
 We next assessed whether ES-derived, Ctip2-expressing, immature neurons are 
appropriately molecularly distinct from other subtypes. During mid-corticogenesis, in 
vivo, when only a small percentage of neurons express NeuN, neocortical projection 
neurons co-express markers characteristic of multiple subtypes. By the first week of 
postnatal neocortical development, this molecular co-expression resolves into a refined, 
subtype-specific molecular identity, termed “subtype refinement” (Lai et al., 2008; Joshi 
et al., 2008; Azim et al., 2009; Cederquist et al., 2013; Lickiss et al., 2012). One 
example transcription factor, Satb2, is transiently expressed by early-stage CFuPN, but 
is later restricted to specific expression by CPN and other associative neocortical 
neurons (Alcamo et al., 2008; Britanova et al., 2008; Lickiss et al., 2012). To specifically 
investigate this subtype refinement of Ctip2 and Satb2 in vivo, for comparison to the 
events in culture, we assessed E16.5 neocortex and find significant Ctip2/Satb2 co-
expression in layer V; these immature Ctip2/Satb2 co-expressing post-mitotic neurons 
consistently do not express NeuN (Figure 5A).  
  26 
 As a further, direct comparison, we next assessed post-mitotic subtype 
refinement by primary developing neocortical neurons in vitro using dissociated E12.5 
neocortical cells cultured under the same conditions as day 14-21 ES-derived 
neocortical neurons. We find that these primary neurons reduce their initially high levels 
of Ctip2 and Satb2 co-expression, and increase the intensity of either Ctip2 or Satb2 
over the course of four days in vitro (Figure 5B-D), confirming that primary neurons are 
capable of subtype-specific transcription factor refinement during maturation in vitro.  
 We then investigated whether the small population of ES-derived, Ctip2-
expressing, immature neocortical neurons similarly display molecular profiles consistent 
with mid-corticogenesis, and whether this molecular identity refines to subtype 
specificity over time. We find that most Ctip2-expressing neurons continue to co-
express Satb2 at 21 days (one week after the onset of in vitro neurogenesis) (Figure 
5E). Strikingly, Ctip2/Satb2 co-expression is still maintained after 28 days of post-mitotic 
differentiation (Figure 5F), in contrast to primary dissociated E15.5 neocortical neurons 
cultured for only four days under the same conditions in vitro (Figure 4B-D). Moreover, 
these ES-derived neocortical-like neurons express a continuum of low, medium, and 
high expression levels of Ctip2 and Satb2, in contrast to primary dissociated E15.5 
neocortical neurons, which have distinctly high, low, or absent expression levels of 
Ctip2 or Satb2, when cultured under the same conditions in vitro.  
 
Incomplete molecular area refinement of ES-derived CFuPN 
 It has been previously reported that some ES cell-derived neurons, when grafted 
in the white matter tracts ventral to the neocortex of P0/P1 mice, project axons to intra-
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cortical and subcerebral (mostly visual) targets after one month (Gaspard et al., 2008). 
The expression of a single caudal neocortex marker, CoupTF1, was used to explain 
these biased projection patterns. Since the time of that publication, multiple transcription 
factors (e.g., Bhlhb5, CoupTF1, and Lmo4) have been characterized as important post-
mitotic controls over neocortical area specification in vivo (Joshi et al., 2008; Armentano 
et al., 2007; Tomassy et al., 2010; Huang et al., 2009; Cederquist et al., 2013). In 
striking parallel to initially broad expression of genes that refine over time to define 
precise subtype identity, these post-mitotic area controls are initially co-expressed 
broadly in all neocortical areas, then become refined in expression during the first 
postnatal week (Woodworth et al., 2012; Custo Greig et al., 2013).  
 To investigate whether immature ES-derived CFuPN might have area-specific 
molecular identity, we assessed putative CFuPN marked by high Ctip2 expression. We 
find that nearly all ES cell-derived Ctip2-expressing neurons co-express CoupTF1 
(Figure 6A), which is consistent with in vivo broad expression (caudal-high to rostral-
low gradient) in the neocortex at mid-corticogenesis. In striking contrast, Ctip2-
expressing neurons do not co-express Bhlhb5 (Figure 6B), although Bhlhb5 is 
expressed by other ES-derived neurons (Figure 6C). These data indicate that the 
absence of Bhlhb5 co-expression is inappropriate for the same stage of development in 
vivo, and might represent deficits in area-specific differentiation by ES-derived 
neocortical neurons. 
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Discussion  
 The experiments presented here are the first to deeply investigate the 
differentiation of neocortical-like neurons derived from ES cells, using the current and 
rapidly advancing knowledge in the field, and the results identify maturation deficits of 
these neurons. We demonstrate the utility of coordinating markers of neuronal 
maturation with markers of neocortical subtypes to assess the stage and extent of 
neocortical differentiation. Previous reports of ES-derived neocortical neuronal subtypes 
have assessed the presence of individual markers or, less commonly, combinations of 
very limited and relatively broad markers to identify neocortical subtypes (Gaspard et 
al., 2008; Eiraku et al., 2008; Nasu et al., 2012; Ideguchi et al., 2010; Mariani et al., 
2012; Shi et al., 2012; Espuny-Camacho et al., 2013). However, most neocortical 
subtype-specific markers are only truly specific during transient developmental stages, 
in defined anatomical locations, and are not individually specific to the neocortex 
(Molyneaux et al., 2007; Woodworth et al., 2012; Custo Greig et al., 2013).  
 Developmental stage-specific characterizations of ES-derived neocortical-like 
neurons in vitro suggest that these neurons most resemble in vivo immature, un-refined 
neocortical neurons at mid-corticogenesis. This conclusion is based on three distinct 
developmental criteria. First, less than one third of TuJ1-expressing neocortical-like 
neurons express mature neuronal markers (MAP2, NeuN), consistent with the 
proportion of neocortical neurons that express NeuN in vivo at E16.5-E18.5 (Figure 4). 
These data provide a metric for comparison to a similar developmental stage in vivo; we 
use this information to interpret the stage-specific expression of subtype markers. 
Second, neocortical-like neurons co-express multiple subtype-specific transcription 
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factors (e.g., Tbr1, Ctip2, Satb2) in a continuum of low, medium, and high expression 
levels consistent with in vivo co-expression of these genes during early- to mid-
corticogenesis, but which is in striking contrast to the more mature expression of these 
transcription factors by primary, dissociated E15.5 neocortical neurons cultured under 
the same conditions in vitro (Figure 3; Figure 5). Third, neocortical-like neurons 
appropriately co-express some, but not all, post-mitotic controls over area-specific 
differentiation (e.g., CoupTF1, Bhlhb5; Figure 6); while this expression profile is most 
consistent with caudal fates, it does not reflect the broad patterns of area-specific 
markers during mid-corticogenesis.  
Neocortical projection neurons are not the only population that displays 
increasingly restricted expression of subtype-specific transcription factors during 
maturation; indeed, spinal motor neurons (SMN) follow a similar process of refinement 
and diversity generation in vivo (Jessell, 2000; Dasen and Jessell, 2009; Alaynick et al., 
2011). Initially, early post-mitotic SMN express the transcription factors Hb9, Islet1, and 
Lhx3 (Sharma et. al., 1998), and with continued maturation and position-dependent 
differentiation (Sürmeli et al., 2011), expression of each transcription factor becomes 
progressively restricted to distinct SMN subtype identities, including medial, lateral, and 
hypaxial motor column subtypes. However, in vitro subtype-specific molecular 
refinements by heterogeneous ES-derived SMN are not distinct at early, immature 
stages of differentiation (Wichterle et al., 2002; Soundararajan et al., 2006; Peljto and 
Wichterle, 2011). Our findings, though directed toward characterizing neocortical 
neuronal identities, also reveal unresolved, immature subtype refinement in vitro. 
Though ES-derived neocortical-like neurons recapitulate some aspects of 
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immature neocortical development specific to a stage approximating mid-
corticogenesis, these data also indicate that these neurons are “stalled” in maturation in 
vitro. This conclusion is based on the comparison of subtype refinement by primary 
dissociated neocortical cells and ES-derived neocortical neurons under the same 
culture conditions (Figure 5). The immature subtype marker profiles in ES-derived 
neurons do not resolve over the course of two weeks in vitro, in contrast to the timing 
observed in vivo, or to primary neurons cultured with the same conditions in vitro. The 
conclusion that ES-derived neocortical-like neurons are stalled in differentiation, rather 
than permanently mis-specified, is supported by evidence of continued neuronal 
maturation, based on the extension of long-range axons to forebrain and midbrain 
targets but not by resolution of subtype-specific molecular markers, following 
transplantation into early post-natal mice (Gaspard et al., 2008). 
 Increasingly, more refined analyses of ES-derived neuron physiology and 
subtype identity indicates stalled or incomplete neuronal differentiation following 
directed differentiation in vitro. For example, in one protocol of SMN generation from 
mouse ES cells, in vitro maturation is limited; only after five days of myotube co-culture 
do ES-derived SMN express more mature physiologic properties of post-natal spinal 
motor neurons (Miles et al., 2004). Recently, more detailed analyses of ES-derived 
photoreceptor neurons (Eiraku and Sasai), midbrain-like dopaminergic neurons (Kriks et 
al., 2011), and spinal nociceptor neurons (Chambers et al., 2012), similarly suggest 
variability and limitations in the extent of neuronal subtype maturation in vitro, and 
following grafting in vivo. 
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 We speculate that the maturation deficits in ES-derived neocortical neurons are 
the result of both intrinsic and extrinsic deficits. First, recent mouse studies demonstrate 
that the absence of specific intrinsic factors might accelerate, delay, or interrupt mature 
laminar or area positioning (e.g., Sox5 in Lai et al., 2008; FoxG1 in Miyoshi and Fishell, 
2012; Bhlhb5 in Joshi et al., 2008; CoupTF1 in Tomassy et al., 2010, and Alfano et al., 
2011). The finding that Bhlhb5 is absent in ES-derived neocortical-like neurons at mid-
corticogenesis is consistent with at least one intrinsic deficit in area-specific 
transcriptional refinement. Second, simplified growth and media conditions in vitro might 
exclude extrinsic factors necessary for neocortical subtype distinction (reviewed in 
Tiberi et al., 2012). Co-culturing with astrocytes might be beneficial, particularly for 
synaptic maturation and other refinements that occur later in postnatal development 
(Johnson et al., 2007; Foo et al., 2011), although the deficits of subtype-specific 
molecular refinement by ES-derived neocortical neurons occur prior to the stage that 
coincides with post-natal gliogenesis. Third, the absence of cell-cell interactions in 
adherent cell culture might impede subtype-specific refinements; strikingly, subtype 
marker overlap does not appear to be as severe in aggregate-based protocols of ES-
derived neocortical differentiation, possibly indicating the utility of cell-cell interactions 
within self-organized ES-derived aggregates (Eiraku et al., 2008; Nasu et al., 2012). 
Similarly, subtype-specific maturation of ES-derived neocortical-like neurons might 
occur when transplanted as individually isolated neurons in vivo, into embryonic or post-
natal neocortex, although such subtype characterizations have not been performed in 
situ (Gaspard et al., 2008). Finally, intrinsic deficits in the chromatin landscape might 
contribute to the stalled maturation of ES-derived neocortical-like neurons; recent 
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studies suggest that chromatin remodeling is important at multiple stages of 
corticogenesis (MacDonald and Roskams, 2009; Tiberi et al., 2012; Baranek et al., 
2012). We speculate that some of these deficits might contribute to the insufficiency of 
ES-derived progenitors, by multiple protocols, to generate distinct superficial-layer 
neuron subtypes (Hansen et al., 2011). 
 Early deficits in pallial progenitor specification might explain the sparse 
enrichment and stalled maturation of post-mitotic neocortical neurons. Our data 
presented here describe heterogeneity of pallial and forebrain markers (e.g., Pax6, 
Sox6, Otx2, and Mash1) and absence of subpallial markers in ES-derived progenitors 
(Figure 2). While these data suggest that dorsalization of ES-derived progenitors is 
highly efficient, the heterogeneity and minimally overlapping expression of multiple 
pallial markers (e.g. Pax6 and Sox6) strongly indicate an incomplete extent of pallial 
differentiation by most ES-derived progenitors. In particular, the strikingly low efficiency 
of neocortical-like neuron generation (at most 20% of ES-derived neurons express Tbr1, 
Ctip2, or Satb2) supports the interpretation that most ES-derived pallial-like progenitors 
are incompletely specified. We speculate that the small population of Pax6 and Sox6 
co-expressing progenitors (~20% of total progenitors; Figure 2C) most closely 
resembles true pallial progenitors and likely accounts for the small population of 
neocortical-like neurons; the prospective isolation of these ES-derived pallial-like 
progenitors might enable further study of neocortical subtype specification in future 
studies. Together, these data suggest that deficits in neocortical-like neuron subtype 
specification might originate with incomplete pallial progenitor specification. 
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 Judging from the typically exceptional specificity of neocortical neuronal subtype 
involvement with specific neurodegenerative diseases (e.g., CSMN and spinal motor 
neurons in ALS; cortico-striatal projection neurons in Huntington’s disease), the utility of 
directed differentiation for studying neocortical biology, pathologic mechanisms, and 
potential therapies likely hinges on its close approximation to in vivo development. 
While the results presented in this report suggest caution in utilizing ES-derived 
neocortical cells as a model for cortical development, with further refinements these 
protocols might be substantially improved. For example, the same protocol for ES-
derived neocortical directed differentiation was recently used as a model system to 
identify Bcl6 as a regulator of neocortical progenitors, and this pathway was verified in 
vivo (Tiberi et al., 2012). Absent a mechanistic understanding of the deficits of ES-
derived neocortical neuron differentiation, these data indicate specific directions for the 
continued refinement of directed differentiation to more closely approximate neocortical 
development. For example, deficits in the transcriptional state or chromatin landscape of 
ES-derived neurons might be targeted for manipulation to enhance neocortical 
differentiation (Juliandi et al., 2012).  
 Taken together, the data from these experiments and from prior work by other 
groups indicate that ES-derived neocortical differentiation is limited in vitro, with multiple 
maturation deficits not consistent with in vivo development. The stage-specific, multiple-
marker methodology presented here promises to be increasingly useful for the 
characterization of neocortical subtypes, and for potentially directing the differentiation 
of refined subtypes. These results provide both foundation and motivation for refining, 
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enhancing, and enriching for directed differentiation of clinically important CFuPN as a 
class, and of distinct cortical projection neuron subtypes. 
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Figure Legends 
 
Figure 1. Sequential generation of neural progenitors, neurons, and astroglia in 
an established monolayer ES cell protocol is reproducible. (A, B) Nestin expression 
decreases, as a proportion of total cells, from day in vitro (DIV) 14 to DIV 21. (C, D) 
TuJ1 expression increases, as a proportion of total cells, from day 14 to day 21. (E, F) 
GFAP expression begins by day 28. (G) Quantification of Nestin, TuJ1, GFAP 
expression over the course of 28 days. Data are represented as mean +/- s.e.m. (N = 
3). Scale bar: panel A, and also for panels B–F, 20um. 
 
Figure 2. Pallial-like progenitors generated by ES-derived progenitors are 
molecularly heterogeneous. (A, B) Half of Nestin-expressing progenitors co-express 
Pax6 (A) or Sox6 (B). (C) ~20% of progenitors express both Pax6 and Sox6. (D, E) The 
majority of Pax6 (D) and Sox6 (E) pallial progenitors co-express Otx2. (F) Ngn2 is 
expressed by some Pax6 low/negative progenitors. (G) Mash1/Nestin subpallial-like 
progenitors represent ~10% of cells. (H-J) Ventralized ES cells lose Pax6 expression 
(H), and increase subpallial Nkx2.1 (I) and Gsh2 (J). (K, L) Pax6/Mash1 (K) and 
Sox6/Mash1 (L) cellular subsets are mostly distinct. Scale bar: panel A, and also for 
panels B-L, 10um. A magenta-green version of this figure is available as a 
supplementary figure.  
 
Figure 3. ES-derived, Ctip2-expressing neurons are neocortical-like. (A) Tbr1-
expressing neurons co-express TuJ1. (B) Ctip2-expressing neurons co-express TuJ1. 
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(C) Ctip2-expressing neurons co-express Tbr1. (D) Ctip2-expressing cells are distinct 
from GAD67-expressing cells; Er81 is co-expressed by Ctip2 neurons (filled 
arrowheads: Ctip2/Er81; empty arrowheads: GAD67). Scale bar: panel A, and also for 
panels B-D, 10um. A partial magenta-green version of this figure is available as a 
supplementary figure. 
 
Figure 4. ES-derived, Ctip2-expressing neurons are immature, consistent with 
NeuN expression at mid-corticogenesis in vivo. (A) Approximately one third of ES-
derived, Ctip2-expressing neurons co-express Map2 and NeuN in vitro (arrows: 
Ctip2/Map2/NeuN) (B,C) In vivo, NeuN is normally expressed by one third of (B) E16.5 
and (C) E18.5 Ctip2-high neurons. (D) By P6, in vivo, all retrograde-labeled SCPN co-
express Ctip2 and NeuN, indicating completion of a next stage of progressive 
maturation. Scale bars: panel A, 10um; panel B, and also for panel C, 150um; panel D, 
30um. A partial magenta-green version of this figure is available as a supplementary 
figure. 
 
Figure 5. ES-derived, Ctip2-expressing neurons do not resolve immature 
projection neuron marker expression over one week in vitro. (A) At E16.5 in vivo, 
Ctip2 and Satb2 co-expressing neurons are relatively immature neurons, indicated by 
the absence of NeuN co-labeling. (B, C, D) Dissociated primary E15.5 neocortical cells 
initially co-express Ctip2 and Satb2, but this immature expression resolves during the 
course of four days in vitro (DIV). (E, F) Under the same culture conditions, ES-derived 
neocortical-like neurons co-express Ctip2 and Satb2 at 21 days (E) and this co-
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expression persists at 28 days (F). Scale bars: panel A, 150um; panel B, and also for 
panels C-F, 10um. A magenta-green version of this figure is available as a 
supplementary figure. 
 
Figure 6. ES-derived, Ctip2-expressing neurons do not complete post-mitotic area 
refinements. (A) All ES-derived Ctip2-expressing neurons co-express CoupTF1. (B) All 
ES-derived Ctip2-expressing neurons cells exclude Bhlhb5. (C) Bhlhb5 is expressed by 
other ES-derived neurons (N=4; approximately 1,000 neurons were screened). Scale 
bar: panel A, and also for panels B-C, 10um. A magenta-green version of this figure is 
available as a supplementary figure. 
 






